The removal of a double chin used to require invasive surgery that was expensive and required more down time than an injectable approach. Now, there is a solution for double chin reduction that does not involve surgery. It is a simple injectable drug called Kybella, which has just been approved for cosmetic use by the Food and Drug Administration.

A proprietary formulation of a synthetic version of deoxycholic acid, Kybella is an injectable drug that can target the fat cells that cause double chin. Deoxycholic acid is naturally produced by the liver and stored in the gall bladder and helps break down dietary fat. Kybella injections harness these properties to destroy the membranes of fat cells, which are then absorbed by the body. It is, in essence, a fat melter that can be the non-surgical solution to double chin removal.

The FDA approved drug now offers a non-surgical approach to patients seeking double chin reduction. Currently, it is only approved for the chin area and it must be applied by skilled professional. To safely remove double chin, the doctor has to inject Kybella directly into fat cells.

Kybella is a huge breakthrough in non-invasive double chin removal. Patients can see results in as little as a few days as fat begins to melt away.

Medical Director at Reflections Center

Dr. Mitchell Chasin founded Reflections Center for skin & body as a place where physicians specializing in cosmetic medicine could focus on helping empower patients to feel their most beautiful. Dr. Chasin believes strongly that the best cosmetic physicians are those who are dedicated to mastering their craft through continuing education and collaboration with the industry’s top doctors.

  • Share: